Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems

By Sean Whooley | November 4, 2020

Nostrum Laboratories is initiating the voluntary recall of two lots of its Metformin HCI extended-release tablets for people with diabetes.

According to an FDA news release, the Metformin HCI extended-release tablets (USP 750mg) were found to contain levels of nitrosamine impurities above the ADI limit of 96ng per day, as stipulated in the FDA Guidance Document issued in September 2020.

Affected products fall under the NDC 29033-056-01 and include two lot numbers — MET200101 and MET200301 — both of which expire in May 2022.

Kansas City, Mo.-based Nostrum Labs has not received any reports of adverse events related to the recall of its product that is indicated as an adjunct to diet and exercise to improve blood glucose control in adults with Type 2 diabetes mellitus.

The company is notifying its distributors by letter and is arranging for the return of all recalled products. Pharmacies carrying the tablets should return them to the place of purchase, while consumers should consult a healthcare professional to obtain a replacement or a different treatment option.

It could be dangerous for patients with Type 2 diabetes to stop taking the metformin without consulting a healthcare professional, the FDA said, and consumers should contact their physician or provider if they have experienced any problems related to the drug.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Seagen
Seagen CEO Siegall resigns after domestic abuse arrest
Moderna
Moderna’s new CFO leaves after former employer discloses investigation
Pfizer logo
Pfizer to shell out $11.6B for migraine drugmaker Biohaven
Novartis logo
Novartis temporarily halts production of two radioligand therapy medicines

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards